- Women with cervical length
Why this matters
- Preterm birth is the number 1 cause of neonatal morbidity and mortality worldwide and is responsible for long-term childhood disability in the United States.
- Currently, the Society for Maternal-Fetal Medicine and the American College of Obstetricians and Gynecologists endorse the use of vaginal progesterone for a short cervix.
- Cerclage plus vaginal progesterone was associated with a greater mean gestational age at delivery (34 weeks, 3 days vs 27 weeks, 2 days; P<.001>
- In the cerclage plus progesterone group:
- 17 preterm births;
- 2 were indicated.
- In the progesterone-alone group:
- 33 preterm births;
- 1 was indicated.
- Neonatal ICU admissions lower in the cerclage plus progesterone group compared with progesterone alone (36.1% vs 65.7%; P=.018).
- Retrospective cohort study of women (age, ≥18 years) with a singleton pregnancy who had at least 2 transvaginal ultrasound cervical length measurements
- Women were allowed to continue vaginal progesterone alone (n=39) or receive a cervical cerclage in addition to progesterone (n=36).
- Funding: None disclosed.
- Study is retrospective.
- Small numbers included.